𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma : A report from the children's oncology group

✍ Scribed by David A. Rodeberg; Julie A. Stoner; Norbert Garcia-Henriquez; R. Lor Randall; Sheri L. Spunt; Carola A. Arndt; Simon Kao; Charles N. Paidas; Lynn Million; Douglas S. Hawkins

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
242 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II investigation of docetaxel in p
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors : A report from the Children's Oncology Group
✍ Ted Zwerdling; Mark Krailo; Philip Monteleone; Rebecca Byrd; Judith Sato; Rose D πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Docetaxel, which is an antitubulin agent, has demonstrable activity against murine and human tumors. The current study was designed to determine response rates to docetaxel in various strata of recurrent solid tumors of childhood and to assess toxicity in a group of patie

Reproductive history, infertility treatm
Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome : A Report From the Children's Oncology Group
✍ Susan E. Puumala; Julie A. Ross; Andrew F. Olshan; Leslie L. Robison; Franklin O πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Children with Down syndrome (DS) have from 10 to 20 times the risk of developing acute leukemia than the general pediatric population. There is mixed evidence for associations between reproductive history or infertility and acute leukemia among children without DS. ## M

Phase 2 study of temozolomide in childre
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors : A report from the Children's Oncology Group
✍ H. Stacy Nicholson; Cynthia S. Kretschmar; Mark Krailo; Mark Bernstein; Richard πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad

Efficacy of ifosfamide and doxorubicin g
Efficacy of ifosfamide and doxorubicin given as a phase II ?window? in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group
✍ Sandler, E. ;Lyden, E. ;Ruymann, F. ;Maurer, H. ;Wharam, M. ;Parham, D. ;Link, M πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 146 KB

## Abstract ## Background The cure rate for children/adolescents with localized rhabdomyosarcoma (RMS) has tripled over the past 25 years, but patients with metastatic disease at presentation have not benefited similarly, and urgently need new therapy. We evaluated a new drug pair, ifosfamide + do